The Korean Severe Asthma Registry (KoSAR): real world research in severe asthma

KoSAR investigators

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

Severe asthma constitutes a serious health burden with significant morbidity and socio-economic costs. The development and introduction of new biologics targeting type 2 in-flammation changed the paradigm for management of severe asthma and initiated a biological era. These changes impose a challenge to clinicians in managing difficult-to-treat and severe asthma. To understand the characteristics and heterogeneity of severe asthma and to develop a better strategy to manage it, the Korean Academy of Asthma, Allergy and Clinical Immunology, Working Group on Severe Asthma, has organized the Korean Severe Asthma Registry (KoSAR). In this review, we describe the challenges of severe asthma management regarding diagnosis, disease burden, heterogeneity, guidelines, and organization of severe asthma clinics. This review also examines the current global activities of national and regional registries and study groups. In addition, we present the KoSAR vision and organization and describe the findings of KoSAR in comparison with those of other countries.

Original languageEnglish
Pages (from-to)249-260
Number of pages12
JournalKorean Journal of Internal Medicine
Volume37
Issue number2
DOIs
StatePublished - Mar 2022

Keywords

  • Biological products
  • Real world
  • Registries
  • Severe asthma

Fingerprint

Dive into the research topics of 'The Korean Severe Asthma Registry (KoSAR): real world research in severe asthma'. Together they form a unique fingerprint.

Cite this